1. Greece Stocks

  2. •

    Healthcare

  3. •

    Medical - Care Facilities
Athens Medical C.S.A.

Athens Medical C.S.A.

IATR.AT
Athens Medical C.S.A.GR flagAthens Stock Exchange
1.80
EUR
+0.01
- -
155.69MMarket Cap

Total Valuation

Athens Medical C.S.A. carries a market capitalization of 155.69M, placing it among publicly traded companies globally. Its enterprise value stands at 191.75M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap155.69M
Enterprise Value191.75M

Share Statistics

Athens Medical C.S.A. currently has 86.74M shares outstanding.

Shares Outstanding86.74M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 0.33, and the price-to-book ratio stands at 2.54.

PE RatioN/A
PS Ratio0.33
PB Ratio2.54
P/TBV Ratio0.90
P/FCF Ratio4.11
P/OCF Ratio4.11

Enterprise Valuation

On an enterprise value basis, Athens Medical C.S.A. trades at an EV/EBITDA multiple of 42.04 and an EV/FCF ratio of 11.40. The EV/Sales ratio of 1.21 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 42.04 provides insight into valuation relative to core operating earnings.

EV / Sales1.21
EV / EBITDA42.04
EV / EBIT42.04
EV / FCF11.40

Financial Position

Athens Medical C.S.A. maintains a current ratio of 0.46, meaning it holds 0.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 253.40, indicating elevated leverage, while an interest coverage ratio of -3.29 demonstrates limited ability to service its debt obligations.

Current Ratio0.46
Quick Ratio0.04
Debt / Equity253.40
Debt / EBITDA-11.18
Interest Coverage-3.29

Financial Efficiency

Return on Equity (ROE)-55.85
Return on Assets (ROA)-4.20
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover28.52

Taxes

Income Tax-475,000.00
Effective Tax RateN/A

Stock Price Statistics

Athens Medical C.S.A.'s stock has declined approximately -0.82872928% over the past 52 weeks. The 50-day moving average sits at 1.81, while the 200-day moving average is 1.87.

Beta (5Y)N/A
52-Week Price Change-0.82872928%
50-Day Moving Average1.81
200-Day Moving Average1.87
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Athens Medical C.S.A. generated 158.09M in revenue and converted that into -15.77M in net income, yielding earnings per share of -0.18. EBITDA reached -13.34M, while operating income came in at -13.34M.

Revenue158.09M
Gross Profit26.26M
Operating Income-13.34M
Pretax Income-16.25M
Net Income-15.77M
EBITDA-13.34M
EBIT-13.34M
Earnings Per Share (EPS)-0.18

Balance Sheet

Athens Medical C.S.A. holds 10.43M in cash and equivalents against 149.12M in total debt, resulting in a net debt position of 138.56M. Total book value stands at 20.83M, with working capital of -146.87M providing operational flexibility.

Cash & Cash Equivalents10.43M
Total Debt149.12M
Net Debt138.56M
Equity (Book Value)20.83M
Book Value Per Share0.24
Working Capital-146.87M

Cash Flow

Athens Medical C.S.A. produced 12.89M in operating cash flow over the past twelve months.

Operating Cash Flow12.89M
Capital ExpendituresN/A
Free Cash Flow12.89M
FCF Per Share0.15

Margins

Athens Medical C.S.A. operates with a gross margin of 16.61, reflecting its pricing power and cost economics. The operating margin of -8.44 and net profit margin of -9.98 provide insight into operational efficiency.

Gross Margin16.61
Operating Margin-8.44
Pretax Margin-10.28
Profit Margin-9.98
EBITDA Margin-8.44

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield11.11
FCF Yield24.34

Scores

Athens Medical C.S.A. posts an Altman Z-Score of -0.09, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-0.09